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An increasing number of pertussis-like cases are attributed to the emergent pathogen Bordetella holmesii. The genomes of 9 clin-
ical isolates show that they are clonal, lack the virulence factors encoded by B. pertussis, and are more similar to nonpertussis
bordetellae. New markers for B. holmesii can be developed using these sequences.
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An increasing number of pertussis-like cases in the UnitedStates and Europe are attributed to the emergent pathogen
Bordetella holmesii (1, 2). An analysis of the 2010-2011 outbreak in
Ohio showed that B. holmesii was detected in nearly 20% of
pertussis-like illnesses (1), up from ~1% in the 1990s (3, 4). Only
three whole-genome sequences are available for this group of
pathogens (5–7). B. holmesii genomes do not encode known Bor-
detella pertussis virulence factors, though they share a genomic
island that contains the IS481 insertion element (7) commonly
used to diagnose B. pertussis infections and leading to common
misidentifications. More specific diagnostic tests were developed
using the B. holmesii-specific IS1001 element (4), but it is unclear
whether this marker is sufficient due to sparse genomic data.
Here, we report the genome sequences of 9 clinical isolates
obtained between 2004 and 2011: six from patients with bactere-
mia (five from blood and one from synovial fluid) and three re-
spiratory isolates from patients with pertussis-like symptoms. A
respiratory isolate was from an infant who had a coinfection with
B. pertussis. Genomic DNA was prepared (8) and sequenced using
a combination of 3- or 5-kb mate-pair (~30 coverage) and
100-bp Illumina paired-end reads (~50 coverage). After quality
trimming, all reads were used in assemblies with Celera Assembler
6.1 (9) or Velvet Assembler. Underlying consensus sequences and
gaps were improved using custom scripts. All genomes had be-
tween 119 and 213 contigs (Table 1). The overall GC content
was ~62.6%, with genome sizes ranging from 3.55 Mb to 3.59 Mb.
B. holmesii isolates belonged to the same multilocus sequenc-
ing type (MLST), as seen in B. pertussis strains (10), suggesting that
the B. holmesii isolates were also clonal. The genomes were anno-
tated and predicted to have between 3,118 and 3,285 genes. The
genomic content of the B. holmesii strains was more similar to
those of Bordetella avium and Bordetella petrii than to those of
B. pertussis or B. bronchiseptica. However, nearly 66% of the genes
were shared with B. pertussis or Bordetella bronchiseptica. Almost
400 genes were shared by all B. holmesii isolates but were not
present in any other bordetellae, likely due to acquisition via hor-
izontal transfer. Many of these genes were involved in the trans-
port and detoxification of organic compounds and antibiotics.
Each strain had between 24 and 114 unique genes, including one
strain that had residual members of a degraded type III secretion
system, as seen in Escherichia coli (11). As expected, the IS481
element was present in all genomes (32 to 65 copies), as was
BhlIS1001 (5 to 21 copies). The acellular vaccine targets of pertus-











H572 Colorado 2010 Synovial fluid 3,585,459 119 JFZY00000000
H585 Minnesota 2010 Blood 3,587,402 150 JFZZ00000000
H629 New York 2010 Blood 3,475,248 190 JGVZ00000000
H635 California 2010 Respiratory fluid 3,569,022 173 JGAA00000000
H643 Pennsylvania 2010 Blood 3,614,976 193 JGWD00000000
H719 Minnesota 2011 Blood 3,578,998 149 JGWA00000000
H785 Oregon 2011 Respiratory fluid 3,565,090 161 JGWB00000000
H809 New York 2011 Blood 3,584,230 153 JMGZ00000000
04P3421 Massachusetts 2004 Respiratory fluid 3,595,240 213 JGWC00000000
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sis toxin, pertactin, and fimbriae were not present, while filamen-
tous hemagglutinin was encoded by all B. holmesii genomes.
These findings suggest that circulating B. holmesii isolates in
the United States emerged from a single genetic background more
similar to nonpertussis bordetellae. The genomes are a resource
for understanding the pathogenicity and evolution of B. holmesii
and for further developing detection and differentiation strate-
gies.
Nucleotide sequence accession numbers. The B. holmesii
whole-genome shotgun project has been deposited at DDBJ/
EMBL/GenBank under the accession no. described in Table 1. The
version described in this paper is the first version.
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